Evidence map›Paper›PMID 42614685›Full record

ReviewMedComm2026

Abscopal Effect in Radiation Therapy: The Immune Mechanisms and Clinical Advances.

Yihong Dong, Moran Chen, Xupeng Hou, Xiaoya Tang, Xiaoli Yu, Jing Liu

Abstract readReview
In one paragraph

Review in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yihong DongKey Laboratory of Breast Cancer in Shanghai Department of Breast Surgery Fudan University Shanghai Cancer Center Shanghai China.ORCID https://orcid.org/0009-0006-3686-4320
Moran ChenKey Laboratory of Breast Cancer in Shanghai Department of Breast Surgery Fudan University Shanghai Cancer Center Shanghai China.ORCID https://orcid.org/0009-0001-0396-9189
Xupeng HouKey Laboratory of Breast Cancer in Shanghai Department of Breast Surgery Fudan University Shanghai Cancer Center Shanghai China.ORCID https://orcid.org/0009-0000-6330-1773
Xiaoya TangKey Laboratory of Breast Cancer in Shanghai Department of Breast Surgery Fudan University Shanghai Cancer Center Shanghai China.
Xiaoli YuDepartment of Radiation Oncology Fudan University Shanghai Cancer Center Shanghai China.ORCID https://orcid.org/0000-0003-1247-7896
Jing LiuKey Laboratory of Breast Cancer in Shanghai Department of Breast Surgery Fudan University Shanghai Cancer Center Shanghai China.ORCID https://orcid.org/0000-0002-8181-8159

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The abscopal effect is a systemic antitumor response to localized radiotherapy (RT) that has emerged as a central focus in the era of immunotherapy. Clinical evidence demonstrates that local RT can induce regression of distant, nonirradiated metastases, including cases of complete remission. However, the effect remains unpredictable, with marked variation in clinical outcomes ranging from complete regression to paradoxical progression. The mechanistic basis for this heterogeneity and optimal strategies to enhance abscopal effects remain incompletely understood. This review synthesizes current evidence into a mechanistic framework organized around a three-stage immune cascade: ignition, orchestration, and execution. We examine how tumor-intrinsic factors, RT parameters, and biomarkers shape this cascade. We then appraise the clinical trial landscape and discuss how these mechanistic insights may inform patient selection, treatment timing, and radioimmunotherapy combination strategies. Critically, we establish a bidirectional framework distinguishing the favorable abscopal response from the pro-tumorigenic badscopal effect, in which RT paradoxically promotes distant progression through immunosuppressive pathways. By clarifying these mechanisms and variables, this review offers a framework for improving future clinical trial design and advancing the abscopal effect from a sporadically observed phenomenon to a predictable therapeutic strategy.

Indexed as

abscopal effectradioimmunotherapyradiotherapy

Identifiers

PMID42614685
PMCPMC13482354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.